B. Woda

发表

Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S).

Ximing J. Yang, Zhong Jiang, B. Woda, 2004, American journal of clinical pathology.

Can molecular profiling of cytogenetic subgroups draw a roadmap for individualizing therapy in myelodysplastic syndromes?

P. Westervelt, B. Woda, A. Raza, 2006, Future oncology.

Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.

Randy D Gascoyne, R. Gascoyne, R. Fisher, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Centrosome defects and genetic instability in malignant tumors.

H Knecht, B. Woda, P. Quesenberry, 1998, Cancer research.

P504S/&agr;-Methylacyl-CoA Racemase: A Useful Marker for Diagnosis of Small Foci of Prostatic Carcinoma on Needle Biopsy

Ximing J. Yang, Zhong Jiang, Zhong Jiang, 2002, The American journal of surgical pathology.

The utility of flow cytometric immunophenotyping in cytopenic patients with a non-diagnostic bone marrow: a prospective study.

B. Smith, B. Woda, L. Medeiros, 2009, Leukemia research.

X-linked lymphoproliferative syndrome.

B. Woda, J. Sullivan, 1989, Immunodeficiency reviews.

Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663.

P. Kantoff, E. Small, B. Woda, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Detection of 5-bromo-2-deoxyuridine (BrdUrd) incorporation with monoclonal anti-BrdUrd antibody after deoxyribonuclease treatment.

B. Woda, T. Sairenji, S. Takagi, 1993, Cytometry.

Mobility of surface proteins on normal rat macrophages and on a "macrophagelike" rat tumor

B. Woda, J. Yguerabide, J. D. Feldman, 1981, The Journal of cell biology.

Cytogenetic abnormalities in a series of 1029 patients with primary myelodysplastic syndromes

B. Woda, A. Raza, Sa A. Wang, 2008, Cancer.

Cytogenetic abnormalities in a series of 1,029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities.

B. Woda, A. Raza, Sa A. Wang, 2008, Cancer.

The interaction of lymphocyte membrane proteins with the lymphocyte cytoskeletal matrix.

B. Woda, M. B. Woodin, 1984, Journal of immunology.

Expression of translation initiation factor eIF‐2α is increased in benign and malignant melanocytic and colonic epithelial neoplasms

B. Woda, I. Rosenwald, J. Pullman, 2003 .

Florid angiogenesis in mucosa surrounding an ileal carcinoid tumor expressing transforming growth factor-alpha.

B. Woda, G. Barnard, B. Banner, 1997, The American journal of surgical pathology.

Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo.

B. Woda, S. Habu, R. Welsh, 1983, Journal of immunology.

Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts.

K. Rock, B. Woda, M. Retter, 2005, Cancer research.

immunopathological studies Epstein-Barr virus-associated hemophagocytic syndrome: virological and

F. Rivara, B. Woda, G. Koh, 2011 .

Epstein-Barr virus-associated hemophagocytic syndrome: virological and immunopathological studies.

F. Rivara, B. Woda, G. Koh, 1985, Blood.

Epstein-Barr virus-associated hemophagocytic syndrome: virological and immunopathological studies.

F. Rivara, B. Woda, G. Koh, 1985, Blood.

Idiopathic retroperitoneal and mediastinal fibrosis mimicking connective tissue disease.

B. Woda, N. Morad, S. Strongwater, 1987, The American journal of medicine.

A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene.

R. Woodland, B. Woda, M. Atkinson, 2008, Clinical immunology.

IMP3 expression is associated with poor outcome and epigenetic deregulation in intrahepatic cholangiocarcinoma.

Zhong Jiang, B. Woda, A. Mercurio, 2014, Human pathology.

Oncofetal Protein IMP3, a New Diagnostic Biomarker to Distinguish Malignant Mesothelioma From Reactive Mesothelial Proliferation

K. Rock, Zhong Jiang, B. Woda, 2011, The American journal of surgical pathology.

Characterization of the inflammatory cell populations in normal colon and colonic carcinomas

B. Woda, B. Banner, L. Savas, 1993, Virchows Archiv. B, Cell pathology including molecular pathology.

Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors

M. Mihm, C. Lian, R. Scolyer, 2013, Modern Pathology.

Autoimmunity after islet-cell allotransplantation.

B. Woda, C. Hartigan, J. Mordes, 2006, The New England journal of medicine.

Immunohistochemical detection of bcl-2 protein in adenocarcinoma and non-neoplastic cellular compartments of the lung.

B. Woda, A. Fraire, S. Rao, 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease.

B. Woda, A. Raza, J. Cerny, 2006, American journal of clinical pathology.

Cell polarity protein Lgl2 is lost or aberrantly localized in gastric dysplasia and adenocarcinoma: an immunohistochemical study

B. Woda, S. Baker, G. Lauwers, 2009, Modern Pathology.

Loss of cell polarity protein Lgl2 in foveolar-type gastric dysplasia: correlation with expression of the apical marker aPKC-zeta

B. Woda, G. Lauwers, Mikhail Lisovsky, 2010, Virchows Archiv.

CD14 Deficiency Impacts Glucose Homeostasis in Mice through Altered Adrenal Tone

James L. Young, B. Woda, M. Czech, 2012, PloS one.

Expression of transforming growth factor-α and epidermal growth factor receptor in gastrointestinal stromal tumours

Zhong Jiang, B. Woda, F. Vittimberga, 1999, Virchows Archiv.

Cytokine gene expression in the islets of the diabetic Biobreeding/Worcester rat.

Zhong Jiang, B. Woda, Z. Jiang, 1991, Journal of immunology.

Natural Killer Cells and Diabetes Mellitus

B. Woda, 1989 .

Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice.

B. Woda, D. Greiner, J. Mordes, 2000, Blood.

Induction of malignant transformation of cocultivated hematopoietic stem cells by X-irradiation of murine bone marrow stromal cells in vitro.

B. Woda, T. Fitzgerald, J. Greenberger, 1986, Cancer research.

Aberrant overexpression of vascular endothelial growth factor in pancreatic ductal adenocarcinoma is associated with aggressive clinical behavior

B. Woda, Liping Zhang, K. Dresser, 2010 .

Mice scid Lymphoproliferative Disorders in Hu-PBL-Development of EBV-Related Regulation of Human Cell Engraftment and and

B. Woda, D. Greiner, L. Shultz, 2000 .

Expanded CD34+ Human Umbilical Cord Blood Cells Generate Multiple Lymphohematopoietic Lineages in NOD-scid IL2rγ null Mice

R. Woodland, B. Woda, D. Greiner, 2008, Experimental biology and medicine.

Altered Expression of Diabetes in BB/Wor Rats by Exposure to Viral Pathogens

B. Woda, D. Greiner, J. Mordes, 1991, Diabetes.

autoimmunity in islet-allografted NOD / Lt mice disease , induction of skin allograft tolerance , and prevention of recurrent myeloablation and anti-CD 154 antibody : absence of graft-versus-host Allogeneic hematopoietic chimerism in mice treated with sublethal

B. Woda, D. Greiner, J. Mordes, 2000 .

NOD mice have a generalized defect in their response to transplantation tolerance induction.

B. Woda, R. Noelle, R. Noelle, 1999, Diabetes.

Separation and isolation of rat natural killer (NK) cells from T cells with monoclonal antibodies.

B. Woda, R. Welsh, M. McFadden, 1984, Journal of immunology.

MechanismsRejection and Host Death by Different Transplantation Tolerance Causes Graft Viral Abrogation of Stem Cell

B. Woda, R. Welsh, J. Mordes, 2002 .

Immunopathology of diabetes in the RT6-depleted diabetes-resistant BB/Wor rat.

B. Woda, A. Rossini, E. Handler, 1990, The American journal of pathology.

Total Lymphoid Irradiation Prevents Diabetes Mellitus in the Bio-Breeding/Worcester (BB/W) Rat

B. Woda, J. Mordes, A. Rossini, 1984, Diabetes.

Natural killer cell number and function in the spontaneously diabetic BB/W rat.

B. Woda, C. Biron, 1986, Journal of immunology.

Deficiency of phenotypic cytotoxic-suppressor T lymphocytes in the BB/W rat.

B. Woda, C. Padden, A. Like, 1986, Journal of immunology.

BioBreeding/Worcester (BB/Wor) rats are deficient in the generation of functional cytotoxic T cells.

B. Woda, C. Padden, 1987, Journal of immunology.

Eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Analysis of four patients and implications for differential diagnosis and pathogenesis.

B. Woda, M. Rybak, U. Degirolami, 1990, Archives of internal medicine.

Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes

B. Woda, E. Fernandez-cruz, J. D. Feldman, 1980, The Journal of experimental medicine.

Mobility and density of AgB, "Ia", and Fc receptors on the surface of lymphocytes from young and old rats.

B. Woda, J. Yguerabide, J. D. Feldman, 1979, Journal of immunology.

Density of surface immunoglobulin and capping on rat B lymphocytes. I. Changes with aging

B. Woda, J. D. Feldman, 1979, The Journal of experimental medicine.

Anatomic Pathology / A NOVEL PROSTATE CANCER MARKER Discovery and Clinical Application of a Novel Prostate Cancer Marker α-Methylacyl CoA Racemase (P504S)

Ximing J. Yang, B. Woda, Chin-Lee Wu, 2004 .

Hypersensitivity pneumonitis: an immunopathology review.

B. Woda, 2009, Archives of pathology & laboratory medicine.

RAT XENOGRAFT SURVIVAL IN MICE TREATED WITH DONOR-SPECIFIC TRANSFUSION AND ANTI-CD154 ANTIBODY IS ENHANCED BY ELIMINATION OF HOST CD4+ CELLS1

B. Woda, D. Greiner, L. Shultz, 2001, Transplantation.

Selective outgrowth of a posttransplant B-immunoblastic lymphoma expressing a latent membrane protein-1 deletion variant.

B. Woda, P. Quesenberry, G. Pihan, 1997, Transplantation.

Adnexotropic T-cell lymphoma presenting with generalized anhidrosis, progressive alopecia, pruritus, and Sjögren's syndrome.

B. Woda, T. Kupper, G. Pihan, 1998, Journal of the American Academy of Dermatology.

Androgen R eceptor M utations i n A ndrogen-Indepen dent Prostate C ancer: C ancer a nd L eukemia G roup B S tudy 9 663

P. Kantoff, E. Small, B. Woda, 2003 .

Mitogen Responsiveness of Lymphocytes From the BB/W Rat

B. Woda, C. Padden, 1986, Diabetes.

T lymphocytes of young and aged rats. I. Distribution, density, and capping of T antigens.

B. Woda, S. Gilman, J. D. Feldman, 1981, Journal of immunology.

KOC (K Homology Domain Containing Protein Overexpressed in Cancer): A Novel Molecular Marker That Distinguishes Between Benign and Malignant Lesions of the Pancreas

R. Yantiss, K. Rock, D. Andersen, 2005, The American journal of surgical pathology.

Post Transplant Lymphoproliferative Disorders: Risk, Classification, and Therapeutic Recommendations

B. Woda, A. Evens, D. Jagadeesh, 2012, Current Treatment Options in Oncology.

Mosaic tetraploidy and transient GFI1 mutation in a patient with severe chronic neutropenia

P. Newburger, B. Woda, Sa A. Wang, 2008, Pediatric blood & cancer.

Advances in understanding the pathogenesis of HLH

P. Newburger, B. Woda, G. Usmani, 2013, British journal of haematology.

Nonneoplastic Histiocytic Proliferations of Lymph Nodes and Bone Marrow

B. Woda, J. Sullivan, S. Rezk, 2011 .

Parvovirus B19-associated hemophagocytic syndrome.

B. Woda, G. Pihan, N. Blacklow, 1990, Archives of internal medicine.

Induction of angiosarcoma by a c-erbB transducing virus

B. Woda, H. Robinson, S. Tracy, 1985, Journal of virology.

Oncofetal Protein IMP3, a New Cancer Biomarker

Zhong Jiang, B. Woda, Yuna Gong, 2014, Advances in anatomic pathology.

Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations

K. Rock, A. Fischer, V. Zota, 2007, Modern Pathology.

Lateral mobility and capping of rat lymphocyte membrane proteins.

B. Woda, S. Gilman, 1983, Cell biology international reports.

Redistribution of contractile and cytoskeletal components induced by cytochalasin. II. In HeLa and HEp2 cells.

B. Woda, S. Berl, G. Godman, 1980, European journal of cell biology.

Redistribution of contractile and cytoskeletal components induced by cytochalasin. I. In Hmf cells, a nontransformed fibroblastoid line.

B. Woda, S. Berl, G. Godman, 1980, European journal of cell biology.

A high-grade primary leiomyosarcoma of the bladder in a survivor of retinoblastoma.

B. Woda, Y. Lakshmanan, Z. Jiang, 2001, Archives of pathology & laboratory medicine.

Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome.

B. Woda, S. Baker, A. Raza, 2008, Leukemia research.

High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes.

B. Woda, M. Menon, Sa A. Wang, 2011, Leukemia research.

Acute lymphocytic leukemia with eosinophilia and unusual karyotype

P. Newburger, J. Fletcher, B. Woda, 2006, Leukemia & lymphoma.

The phenotype of lymphocytes in a thymoma as studied with monoclonal antibodies.

B. Woda, K. Bain, T. Vander Salm, 1984, Clinical immunology and immunopathology.

Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats

B. Woda, L. Medeiros, A. Raza, 2009, Haematologica.

Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy.

B. Woda, M. Borowitz, P. Herzog, 1986, Blood.

Transformation of follicular lymphoma to Epstein-Barr virus-related Hodgkin-like lymphoma.

E. Jaffe, B. Woda, M. Menon, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Early relapse of Burkitt lymphoma heralded by a bone marrow necrosis and numb chin syndrome successfully treated with allogeneic stem cell transplantation

B. Woda, J. Cerny, M. Ramanathan, 2014, Leukemia research reports.

Acute, lethal, natural killer cell-resistant myeloproliferative disease induced by polyomavirus in severe combined immunodeficient mice.

B. Woda, L. Shultz, R. Welsh, 1994, The American journal of pathology.

Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice

B. Woda, R. Welsh, J. Bukowski, 1984, Journal of virology.

Nodular lymphocytic lymphoma eventuating into diffuse histiocytic lymphoma. Immunoperoxidase demonstration of monoclonality

B. Woda, D. Knowles, 1979, Cancer.

Myelodysplastic syndrome with pure red cell aplasia shows characteristic clinicopathological features and clonal T‐cell expansion

B. Woda, A. Raza, N. Galili, 2007, British journal of haematology.

The lack of specificity of the sheep erythrocyte-T lymphocyte rosetting phenomenon.

B. Woda, C. Fenoglio, D. W. King, 1977, American Journal of Pathology.

IMP3, a New Biomarker to Predict Progression of Cervical Intraepithelial Neoplasia Into Invasive Cancer

K. Rock, Zhong Jiang, B. Woda, 2011, The American journal of surgical pathology.

Expression of adhesion molecules in the host response to colon carcinoma.

B. Woda, B. Banner, L. Savas, 1995, Ultrastructural pathology.

Miliary tuberculosis in a patient with Epstein-Barr virus-associated angioimmunoblastic lymphadenopathy

B. Woda, H. Knecht, J. Selves, 1996, Annals of Hematology.

Respiratory Syncytial Virus

B. Woda, A. Fraire, 2013, Viruses and the Lung.

Liposomes loaded with contrast material for image enhancement in computed tomography. Work in progress.

B. Woda, M. A. Davis, D. L. Melchior, 1984, Radiology.

Simultaneous chronic lymphocytic leukemia and chronic myelogenous leukemia. Evidence of a separate stem cell origin

B. Woda, J. Wallace, P. L. Townes, 1993, Cancer.

IMMUNE COMPLEXES IN RHEUMATIC DISEASE

B. Woda, 1976, The Lancet.

Altered expression of histocompatibility antigens on "B" large cell lymphomas.

B. Woda, H. Rappaport, B. Racklin, 1981, Blood.

Elderly do benefit from induction chemotherapy: High dose mitoxantrone‐based (“5 + 1”) induction chemotherapy regimen in newly diagnosed acute myeloid leukemia

B. Woda, P. Miron, G. Raffel, 2018, American journal of hematology.

Altered expression of histocompatibility antigens on "B" large cell lymphomas

B. Woda, H. Rappaport, B. Racklin, 1981 .

Expression of CD25 independently predicts early treatment failure of acute myeloid leukaemia (AML)

B. Barton, B. Woda, W. Walsh, 2013, British journal of haematology.

Deletion variants within the NF-kappa B activation domain of the LMP1 oncogene prevail in acquired immunodeficiency syndrome-related large cell lymphomas and human immunodeficiency virus-negative atypical lymphoproliferations.

P. Brousset, B. Woda, P. Quesenberry, 1996, Blood.

The oncofetal protein IMP3: a novel molecular marker to predict aggressive meningioma.

K. Rock, Zhong Jiang, B. Woda, 2011, Archives of pathology & laboratory medicine.

IMP2 Expression Distinguishes Endometrioid From Serous Endometrial Adenocarcinomas

B. Woda, Yuxin Liu, S. Hao, 2011, The American journal of surgical pathology.

Radiosensitivity of permanent human bone marrow stromal cell lines: effect of dose rate.

B. Woda, T. Fitzgerald, J. Greenberger, 1988, International journal of radiation oncology, biology, physics.

p53: a good diagnostic marker for intratubular germ cell neoplasia, unclassified.

Zhong Jiang, B. Woda, A. Ayala, 2001 .

p53: A Good Diagnostic Marker for Intratubular Germ Cell Neoplasia, Unclassified

B. Woda, Y. Liu, A. Ayala, 2001, Applied immunohistochemistry & molecular morphology : AIMM.

Tetrasomy 21 in megakaryoblastic leukemia.

B. Woda, L. Potocki, M. Schwenn, 1994, Cancer genetics and cytogenetics.

Langerhans cell histiocytosis with the radiographic findings of Erdheim-Chester disease.

B. Woda, P. Doherty, M. Liepman, 1988, AJR. American journal of roentgenology.

Radiation Therapy and Non-Hodgkin Lymphoma of the Extremity. Case Reports: Strategy for Treatment Planning and Therapy Implementation

B. Woda, Suhong Yu, T. Fitzgerald, 2021, Frontiers in Medical Case Reports.

Acute interstitial nephritis associated with carbenicillin therapy.

B. Woda, H. Neu, G. Appel, 1978, Archives of internal medicine.

Pathology and tumor incidence in aged Lewis and BN rats.

B. Woda, J. D. Feldman, 1980, Clinical immunology and immunopathology.

Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease

J. Casanova, P. Newburger, C. Picard, 2011, Nature Immunology.

Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma

Abraham J. Khorasani, L. Zon, C. Ceol, 2012, Cell.

Regulation of Human Cell Engraftment and Development of EBV-Related Lymphoproliferative Disorders in Hu-PBL-scid Mice1

B. Woda, D. Greiner, L. Shultz, 2000, The Journal of Immunology.

Immunohistochemical loss of 5‐hydroxymethylcytosine expression in acute myeloid leukaemia: relationship to somatic gene mutations affecting epigenetic pathways

B. Woda, K. Dresser, A. Sakhdari, 2016, Histopathology.

Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens.

Zhong Jiang, Andrew Fischer, A. Fischer, 2005, American journal of clinical pathology.

Alpha‐methylacyl‐CoA racemase: a multi‐institutional study of a new prostate cancer marker

Ximing J. Yang, K. Iczkowski, K. Rock, 2004, Histopathology.

P504S immunostaining boosts diagnostic resolution of "suspicious" foci in prostatic needle biopsy specimens.

Ximing J. Yang, K. Iczkowski, Zhong Jiang, 2004, American journal of clinical pathology.

Cells-Diamminedichloroplatinum ( II ) in BE Human Colon Carcinoma cis Characterization of Acquired Resistance to Updated

B. Woda, J. Wilson, N. Robichaud, 2006 .

Interdigitating reticulum‐cell sarcoma of the intestine: A case report and review of the literature

B. Woda, M. Liepman, B. Banner, 1997, Diagnostic cytopathology.

Lymphocyte transfusions prevent diabetes in the Bio-Breeding/Worcester rat.

B. Woda, J. Mordes, A. Rossini, 1984, The Journal of clinical investigation.

Intrinsic Cytotoxicity of Natural Killer Cells to Pancreatic Islets In Vitro

Craig W. Reynolds, B. Woda, J. Ortaldo, 1990, Diabetes.

LEW.1WR1 rats develop autoimmune diabetes spontaneously and in response to environmental perturbation.

B. Woda, D. Greiner, D. Guberski, 2005, Diabetes.

Eosinophilia with FIP1L1-PDGFRA fusion in a patient with chronic myelomonocytic leukemia.

V. Zota, B. Woda, A. Raza, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ligand-induced capping of surface proteins on trifluoperazine-treated macrophages.

B. Woda, M. McFadden, 1982, Experimental cell research.

Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease.

B. Woda, B. Banner, L. Savas, 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Analysis of α-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia

Ximing J. Yang, E. Halpern, Zhong Jiang, 2004 .

Expression of &agr;-Methylacyl-CoA Racemase (P504S) in Atypical Adenomatous Hyperplasia of the Prostate

Ximing J. Yang, Zhong Jiang, B. Woda, 2002, The American journal of surgical pathology.

P504S: A New Molecular Marker for the Detection of Prostate Carcinoma

S. Reed, B. Woda, G. Pihan, 2001, The American journal of surgical pathology.

Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.

Liang Cheng, Zhong Jiang, B. Woda, 2018, The American journal of pathology.

Expression of Translation Initiation Factors eIF-4E and eIF-2α and a Potential Physiologic Role of Continuous Protein Synthesis in Human Platelets

B. Woda, G. Pihan, I. Rosenwald, 2001, Thrombosis and Haemostasis.

Detection of alpha-methylacyl-coenzyme A racemase in postradiation prostatic adenocarcinoma.

Ximing J. Yang, B. Laven, Zhong Jiang, 2003, Urology.

IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16INK4a expression

K. Rock, Zhong Jiang, B. Woda, 2007, Modern Pathology.

Rapid cell blocks improve accuracy of breast FNAs beyond that provided by conventional cell blocks regardless of immediate adequacy evaluation

B. Woda, A. Akalin, L. Moss, 2008, Diagnostic cytopathology.

Viral Abrogation of Stem Cell Transplantation Tolerance Causes Graft Rejection and Host Death by Different Mechanisms1

B. Woda, D. Greiner, R. Welsh, 2002, The Journal of Immunology.

Diagnostic Utility of α-Methylacyl CoA Racemase (P504S) on Prostate Needle Biopsy

Zhong Jiang, B. Woda, 2004, Advances in anatomic pathology.

MYC Immunohistochemistry to Identify MYC-Driven B-Cell Lymphomas in Clinical Practice.

D. Neuberg, P. D. Dal Cin, G. Pinkus, 2016, American journal of clinical pathology.

Sensitivity of P504S/α-Methylacyl-CoA Racemase (AMACR) Immunohistochemistry for the Detection of Prostate Carcinoma on Stored Needle Biopsies

Zhong Jiang, B. Woda, V. Vanguri, 2006, Applied immunohistochemistry & molecular morphology : AIMM.

Expression of α-methylacyl-coa racemase (p504s) in various malignant neoplasms and normal tissues: a study of 761 cases

Zhong Jiang, B. Woda, P. Chu, 2003 .

A dietary enzyme: α-methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma

K. Rock, S. Reed, Zhong Jiang, 2003 .

PD-L 1 expression in EBV-negative diffuse large B-cell lymphoma : clinicopathologic features and prognostic implications

B. Woda, A. Evens, Rui Zhang, 2017 .

PD-L1 expression in EBV-negative diffuse large B-cell lymphoma: clinicopathologic features and prognostic implications

B. Woda, A. Evens, Rui Zhang, 2016, Oncotarget.

Sp1, a New Biomarker That Identifies a Subset of Aggressive Pancreatic Ductal Adenocarcinoma

B. Woda, Naomi Y Jiang, Bruce A Woda, 2008, Cancer Epidemiology Biomarkers & Prevention.

Metabolic Network 12-27-2016 Phosphorylation of the Mdm 2 oncoprotein by the c-Abl tyrosine kinase regulates p 53 tumor suppression and the radiosensitivity of mice

B. Woda, Hong Zhang, M. Kelliher, 2017 .

Phosphorylation of the Mdm2 oncoprotein by the c-Abl tyrosine kinase regulates p53 tumor suppression and the radiosensitivity of mice

B. Woda, Hong Zhang, M. Kelliher, 2016, Proceedings of the National Academy of Sciences.

Oncofetal protein IMP3

K. Rock, C. Lohse, Zhong Jiang, 2008, Cancer.

A Novel Molecular Marker That Predicts Metastasis of Papillary and Chromophobe Renal Cell Carcinomas

K. Rock, C. Lohse, Zhong Jiang, 2008 .

Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: astudy of 761 cases.

Zhong Jiang, B. Woda, P. Chu, 2003, Human pathology.

Combination of Quantitative IMP3 and Tumor Stage: A New System to Predict Metastasis for Patients with Localized Renal Cell Carcinomas

K. Rock, Zhong Jiang, B. Woda, 2008, Clinical Cancer Research.

Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study.

K. Rock, Zhong Jiang, B. Woda, 2006, The Lancet. Oncology.

Alpha-methylacyl coenzyme A racemase as a marker for prostate cancer.

Ximing J. Yang, Zhong Jiang, B. Woda, 2002, JAMA.

Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification

B. Woda, A. Raza, Sa A. Wang, 2008, Modern Pathology.

The effect of local anesthetics on the lateral mobility of lymphocyte membrane proteins.

B. Woda, J. Yguerabide, J. D. Feldman, 1980, Experimental cell research.

The Use of Immunoglobulin Gene Rearrangement Polymerase Chain Reaction Assays for Detection of B-Cell Clonality for Plasma Cell Neoplasms Using Novel PCR Primers

B. Woda, E. Cosar, Paul J. Lee, 2016 .

Cytology specimens offer an effective alternative to formalin‐fixed tissue as demonstrated by novel automated detection for ALK break‐apart FISH testing and immunohistochemistry in lung adenocarcinoma

B. Woda, Joanne Garver, E. Cosar, 2014, Cancer cytopathology.

Hemophagocytic lymphohistiocytosis secondary to T-cell/histiocyte-rich large B-cell lymphoma

B. Woda, M. Ramanathan, Hongbo Yu, 2014, Leukemia research reports.

Facile, comprehensive, high-throughput genotyping of human genital papillomaviruses using spectrally addressable liquid bead microarrays.

B. Woda, G. Pihan, J. Wallace, 2005, The Journal of molecular diagnostics : JMD.

Viral abrogation of stem cell transplantation tolerance causes graft rejection and host death by different mechanisms.

B. Woda, D. Greiner, R. Welsh, 2002, Journal of immunology.

Virus-associated hemophagocytic syndrome: identification of an immunoproliferative precursor lesion.

B. Woda, J. Sullivan, C. Mulder, 1987, Human pathology.

Gamma-irradiation response of cocultivated bone marrow stromal cell lines of differing intrinsic radiosensitivity.

B. Woda, T. Fitzgerald, J. Greenberger, 1990, International journal of radiation oncology, biology, physics.

Parvovirus B19\p=n-\Associated Hemophagocytic Syndrome

B. Woda, G. Pihan, N. Blacklow, 2017 .

Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr, and Bcl-2-transgenic mice.

B. Woda, R. Welsh, E. Razvi, 1995, The American journal of pathology.

Diabetes insipidus caused by extramedullary hematopoiesis.

B. Woda, T. W. Smith, R. Coslovsky, 1985, American journal of clinical pathology.

Hemophagocytic lymphohistiocytosis with MUNC13‐4 gene mutation or reduced natural killer cell function prior to onset of childhood leukemia

P. Newburger, B. Woda, Tamara Y Chang, 2011, Pediatric blood & cancer.

Diagnostic challenges related to myeloid/natural killer cells, a variant of myeloblasts.

B. Woda, Sa A. Wang, O. Fadare, 2008, International journal of clinical and experimental pathology.

Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia.

Ximing J. Yang, E. Halpern, Zhong Jiang, 2004, Human pathology.

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features

B. Woda, A. Raza, R. Hasserjian, 2006, Leukemia.

ATM phosphorylation of Mdm2 Ser394 regulates the amplitude and duration of the DNA damage response in mice.

B. Woda, Hugh S. Gannon, S. Jones, 2012, Cancer cell.

Virus-Induced Abrogation of Transplantation Tolerance Induced by Donor-Specific Transfusion and Anti-CD154 Antibody

B. Woda, D. Greiner, R. Welsh, 2000, Journal of Virology.

Somatic mutations in histiocytic sarcoma identified by next generation sequencing

B. Woda, J. Hornick, Hongbo Yu, 2016, Virchows Archiv.

Rituximab-CHOP Versus CHOP with or without Maintenance Rituximab in Patients 60 Years of Age or Older with Diffuse Large B-Cell Lymphoma (DLBCL): An Update.

R. Gascoyne, R. Fisher, T. Habermann, 2004 .

Cerebellar T-cell lymphoma: an unusual primary intracranial neoplasm

B. Woda, R. Ragland, N. Gelber, 2004, Neuroradiology.

IMP3 Predicts Aggressive Superficial Urothelial Carcinoma of the Bladder

Zhong Jiang, B. Woda, S. Mohanty, 2008, Clinical Cancer Research.

Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy.

Sonali M. Smith, C. Flowers, B. Woda, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Expression of the translation initiation factors eIF-4E and eIF-2* is frequently increased in neoplastic cells of Hodgkin lymphoma.

B. Woda, I. Rosenwald, Jane-Jane Chen, 2008, Human pathology.

Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas.

B. Woda, G. Pihan, I. Rosenwald, 1999, The American journal of pathology.

Predictors of Prostate Cancer Tissue Acquisition by an Undirected Core Bone Marrow Biopsy in Metastatic Castration-Resistant Prostate Cancer—A Cancer and Leukemia Group B Study

P. Kantoff, E. Small, B. Woda, 2005, Clinical Cancer Research.

Five important advances in hematopathology.

B. Woda, Hongbo Yu, Min Shi, 2014, Archives of pathology & laboratory medicine.

A dietary enzyme: alpha-methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma.

K. Rock, S. Reed, Zhong Jiang, 2003, Cancer detection and prevention.

BARCODE-ALL: accelerated and cost-effective genetic risk stratification in acute leukemia using spectrally addressable liquid bead microarrays

P. Newburger, B. Woda, G. Pihan, 2003, Leukemia.

BARCODE-ALL: accelerated and cost-effective genetic risk stratification in acute leukemia using spectrally addressable liquid bead microarrays

P. Newburger, B. Woda, G. Pihan, 2003, Leukemia.

The Fusion of Tumor Cells with Host Cells; Reflections on an Ovarian Tumor

B. Woda, R. Kerschmann, G. Majno, 2015, Perspectives in biology and medicine.

Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma with a complex karyotype and cryptic 3' ALK gene insertion to chromosome 4 q22-24.

N. Harris, B. Woda, Sa A. Wang, 2007, Human pathology.

Anaplastic lymphoma kinase-positive large B-cell lymphoma with complex karyotype and novel ALK gene rearrangements.

B. Woda, P. Miron, Hongbo Yu, 2011, Human pathology.

Maintenance rituximab (MR) compared to observation (OBS) after R-CHOP or CHOP in older patients (pts) with diffuse large B-cell lymphoma (DLBCL): An Intergroup E4494/C9793 update

R. Gascoyne, R. Fisher, T. Habermann, 2007 .

Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls.

Olga Pozdnyakova, Sa A Wang, B. Smith, 2008, Leukemia research.

Chronic basophilic leukemia: a rare form of chronic myeloproliferative neoplasm.

B. Woda, D. Brettler, Sa A. Wang, 2009, Human pathology.

Glomerulonephritis due to Staphylococcus aureus antigen.

B. Woda, D. Brigati, L. Pertschuk, 1976, American journal of clinical pathology.

Dendritic cell phenotype in localized malignant histiocytosis of the small intestine.

B. Woda, M. Liepman, G. Daum, 1985, Archives of pathology & laboratory medicine.

Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL.

I. Lossos, J. Vose, R. Gascoyne, 2017, Blood advances.

Somatic molecular analysis augments cytologic evaluation of pancreatic cyst fluids as a diagnostic tool

B. Woda, W. Wassef, J. Živný, 2019, Oncotarget.

Immunohistochemistry for cell polarity protein lethal giant larvae 2 differentiates pancreatic intraepithelial neoplasia-3 and ductal adenocarcinoma of the pancreas from lower-grade pancreatic intraepithelial neoplasias.

M. Mino‐Kenudson, B. Woda, Mikhail Lisovsky, 2010, Human pathology.

Impact of pretransplant mutation status on survival after allogeneic stem cell transplant for acute myeloid leukemia

B. Woda, Jacob R. Bledsoe, M. Ramanathan, 2021, EJHaem.

Infection With Viruses From Several Families Triggers Autoimmune Diabetes in LEW.1WR1 Rats

B. Woda, D. Greiner, D. Guberski, 2009, Diabetes.

Sonographic findings in primary uterine cervical lymphoma

B. Woda, K. Reuter, A. Malatskey, 1991, Journal of clinical ultrasound : JCU.

Detection of prostate cancer by α‐methylacyl CoA racemase (P504S) in needle biopsy specimens previously reported as negative for malignancy

B. Woda, K. Dresser, X. Wang, 2006, Histopathology.

An Oncofetal Protein IMP3: A New Molecular Marker for the Detection of Esophageal Adenocarcinoma and High-grade Dysplasia

K. Rock, Zhong Jiang, B. Woda, 2009, The American journal of surgical pathology.

MYC Protein Expression Is Detected in Plasma Cell Myeloma but Not in Monoclonal Gammopathy of Undetermined Significance (MGUS)

B. Woda, S. Rodig, K. Dresser, 2014, The American journal of surgical pathology.

Cervista HR and HPV 16/18 assays vs hybrid capture 2 assay: outcome comparison in women with negative cervical cytology.

B. Woda, S. Baker, E. Cosar, 2011, American journal of clinical pathology.

Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.

B. Woda, T. Sairenji, R. Humphreys, 1987, Journal of immunology.

Expression of transforming growth factor-alpha and epidermal growth factor receptor in gastrointestinal stromal tumours.

B. Woda, X. Xu, F. Vittimberga, 1999, Virchows Archiv : an international journal of pathology.

Cancer Biology

B. Woda, J. Liebmann, Elizabeth M. Kurian, 1992, Current opinion in oncology.

IMP 3 Predicts Aggressive Superficial Urothelial Carcinoma of the Bladder

K. Rock, B. Woda, S. Mohanty, 2008 .

Combination of Quantitative IMP 3 andTumor Stage : ANew System to Predict Metastasis for Patients with Localized Renal Cell Carcinomas

K. Rock, B. Woda, Chin-Lee Wu, 2008 .

Reactive histiocytic disorders.

B. Woda, J. Sullivan, 1993, American journal of clinical pathology.

Characterization of acquired resistance to cis-diamminedichloroplatinum (II) in BE human colon carcinoma cells.

B. Woda, J. Wilson, R. Fram, 1990, Cancer research.

Sp 1 , a New Biomarker That Identifies a Subset of Aggressive Pancreatic Ductal Adenocarcinoma

B. Woda, K. Dresser, G. Whalen, 2008 .

Laryngeal mucous membrane plasmacytosis with 15 year follow-up: Case report and literature review

B. Woda, D. Brettler, A. Vaezi, 2019, Leukemia research reports.

The Pathology of Cancer

B. Woda, C. Ok, E. Kurian, 1872, Nature.

Chronic neutrophilic leukemia, a rare case of leukocytosis.

B. Woda, L. Hutchinson, Xin Wang, 2020, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

A unicryptal colonic adenoma, the smallest colonic neoplasm yet observed in a non-polyposis individual.

B. Woda, K. Forde, N. Lane, 1977, American journal of clinical pathology.

Cancer Concepts : A Guidebook for the Non-Oncologist Radiation Oncology 3-8-2016 Cancer Biology

B. Woda, E. Kurian, J. Liebmann, 2017 .

Cancer Concepts : A Guidebook for the Non-Oncologist Radiation Oncology 3-8-2016 Cancer Biology

B. Woda, E. Kurian, J. Liebmann, 2017 .

Cancer Concepts : A Guidebook for the Non-Oncologist Radiation Oncology 4-13-2015 Cancer Biology

B. Woda, J. Liebmann, Elizabeth M. Kurian, 2016 .

Anaplastic lymphoma kinase-positive large B-cell lymphoma with complex karyotype and novel ALK gene rearrangements.

B. Woda, P. Miron, Hongbo Yu, 2011, Human pathology.

Oncofetal Protein IMP3, a New Diagnostic Biomarker to Distinguish Malignant Mesothelioma From Reactive Mesothelial Proliferation

K. Rock, Zhong Jiang, B. Woda, 2011, The American journal of surgical pathology.

Combination of Quantitative IMP3 and Tumor Stage: A New System to Predict Metastasis for Patients with Localized Renal Cell Carcinomas

K. Rock, Zhong Jiang, B. Woda, 2008, Clinical Cancer Research.

IMP3 Predicts Aggressive Superficial Urothelial Carcinoma of the Bladder

Zhong Jiang, B. Woda, S. Mohanty, 2008, Clinical Cancer Research.

Mild Microcytic Anemia in an Infant with a Compound Heterozygosity for Hb C (HBB: c.19G > A) and Hb Osu Christiansborg (HBB: c.157G > A)

P. Newburger, B. Woda, D. Chui, 2016, Hemoglobin.

Survival of Newly Diagnosed T-Cell Lymphoma (TCL) in the Modern Era: Investigation of Prognostic Factors with Critical Examination of Therapy in a Multicenter US Cohort.

E. Winer, Sonali M. Smith, C. Flowers, 2012 .

Guido Majno, MD: 1922–2010

B. Woda, A. Fraire, 2010 .

Expression of CD25 independently predicts early treatment failure of acute myeloid leukaemia (AML)

B. Barton, B. Woda, W. Walsh, 2013, British journal of haematology.

Expression of CD25 on Acute Myeloid Leukemia (AML) Blasts Is An Independent Risk Factor Associated with Refractory Disease, Which May Be Overcome by Stem Cell Transplantation (SCT),

B. Barton, B. Woda, G. Raffel, 2011 .

High Complete Remission (CR) Rates and Reduced Early Mortality with High Dose Ara-c (HiDAC) and Mitoxantrone (MITO) Induction Chemotherapy for Older (age>60) High Risk Patients with Acute Myeloid Leukemia (AML)

B. Woda, W. Walsh, P. Miron, 2010 .